Publications

Search our bibliography using the filters on the right-hand side.

Displaying 151 through 200 of 341 publications.

Zografos LJ, Calingaert B, Davenport EK, Vassilev ZP, Wolin DL, Andrews E. Evaluation of patient knowledge of safety and safe use information for aflibercept in Europe. Poster presented at the 34th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 26, 2018. Prague, Czech Republic. [abstract] Pharmacoepidemiol Drug Saf. 2018 Aug; 27(S2):520. doi: 10.1002/pds.4629

Joshi K, Muser E, Xu Y, Schwab P, Datar M, Suehs B. Adherence and economic impact of paliperidone palmitate versus oral atypical antipsychotics in a Medicare population. J Comp Eff Res. 2018 Aug;7(8):723-35. doi: 10.2217/cer-2018-0003

Magrey M, Bozyczko M, Wolin D, Mordin M, McLeod L, Davenport E, Park Y. Treatment experience and satisfaction in ankylosing spondylitis patients treated with secukinumab: results from a US web-based survey. Poster presented at the 2018 Annual European Congress of Rheumatology (EULAR); June 16, 2018. Amsterdam, The Netherlands.

Trivedi MS, Colbeth H, Yi H, Vanegas A, Starck R, Chung WK, Appelbaum PS, Kukafka R, Schechter I, Crew KD. Understanding factors associated with uptake of BRCA1/2 genetic testing among Orthodox Jewish women in the USA using a mixed-methods approach. Public Health Genomics. 2018 Jun;21(5-6):186-96. doi: 10.1159/000499852

Mitra D, Darden C, McSorley D, Davis K, Band J, Iyer S. Patient reported treatment satisfaction with palbociclib combination therapies for HR+/HER2– advanced or metastatic breast cancer in multiple countries. Poster presented at the 2018 ISPOR 23rd Annual International Meeting; May 22, 2018. Baltimore, MD.

Sluga-O'Callaghan M, Ansquer V, Frugier G, Mai C. Evolution of regulatory requirements for retrospective observational studies using medical records in Austria, Belgium, Italy, Netherlands and Switzerland. Poster presented at the 2018 ISPOR 23rd Annual International Meeting; May 2018. Baltimore, MD. [abstract] Value Health. 2018 May; 21(Suppl 1):S51. doi: 10.1016/j.jval.2018.04.425

Levine C, Ansquer V, Kurosky SK. Factors associated with data collection duration and participation rates in retrospective noninterventional medical record review studies. Poster presented at the 2018 ISPOR 23rd Annual International Meeting; May 21, 2018. Baltimore, MD. [abstract] Value Health. 2018 May; 21(Suppl):S219. doi: 10.1016/j.jval.2018.04.1485

Raspa M, Sacco P, Bailey DB, Visootsak J, Cabo R. Clinical unmet needs and burden in Fragile X syndrome: results of a targeted literature review. Poster presented at the 2018 AMCP Managed Care & Specialty Pharmacy Annual Meeting; April 23, 2018. Boston, MA. [abstract] J Manag Care Pharm. 2018 Apr 24; 24(4-a):S7. Previously presented at the American Association on Intellectual and Development Disabilities 141st Annual Meeting.

Raspa M, Sacco P, Bailey, Jr DB, Visootsak J, Cabo R. Clinical unmet needs and burden in fragile X syndrome: results of a targeted literature review. Poster presented at the 2018 70th Annual AAN Meeting; April 24, 2018. Los Angeles, CA. [abstract] Neurology. 2018 Apr 10; 90(15 Supplement):3.314. Previously presented at the American Association on Intellectual and Development Disabilities 141st Annual Meeting.

P Sacco, Raspa M, Leahy L, Cabo R. A literature review of the economic burden of Fragile X Syndrome. Poster presented at the 70th AAN Annual Meeting; April 24, 2018. Los Angeles, CA. [abstract] Neurology. 2018 Apr 10; 90(15 Supplement):3.319.

McGuinness JE, Ueng W, Trivedi MS, Yi HS, David R, Vanegas A, Vargas J, Sandoval R, Kukafka R, Crew KD. Factors associated with false positive results on screening mammography in a population of predominantly Hispanic women. Cancer Epidemiol Biomarkers Prev. 2018 Apr;27(4):446-53. doi: 10.1158/1055-9965.EPI-17-0009

Hollis K, Proctor C, McBride D, Balp MM, McLeod L, Hunter S, Tian H, Khalil S, Maurer M. Comparison of Urticaria Activity Score over 7 days (UAS7) values obtained from once-daily and twice daily versions: results from the ASSURE-CSU study. Am J Clin Dermatol. 2018 Apr;19(2):267-74. doi: 10.1007/s40257-017-0331-8

Chiang J, Schwab P, McCulloch R, Brooks P, Rhodes C, Happe L. Impact of a retrospective drug utilization review program on changing opioid prescribing behavior. Poster presented at the 2018 AMCP Managed Care & Specialty Pharmacy Annual Meeting; April 23, 2018. Boston, MA. [abstract] J Manag Care Pharm. 2018 Apr; 24(4-a):S11.

Sacco P, Raspa M, Leahy L, Cabo R. A literature review of the economic burden of Fragile X syndrome. Poster presented at the 2018 AMCP Managed Care & Specialty Pharmacy Annual Meeting; April 23, 2018. Boston, MA. [abstract] J Manag Care Pharm. 2018 Apr; 24(4-a):S7. Previously presented at the 70th AAN Annual Meeting.

Darden C, Mitra D, McSorley D, Davis K, Band J, Iyer S. Patient-reported treatment satisfaction among women receiving palbociclib combination therapies for HR+/HER2- advanced or metastatic breast cancer in the United States. Poster presented at the 35th Annual Miami Breast Cancer Conference; March 8, 2018. Miami Beach, FL.

Magrey M, Wolin DL, Mordin MM, McLeod LD, Davenport EK, Hur P. US patient satisfaction with Secukinumab treatment among patients with both psoriatic arthritis and psoriasis: data from a web-based survey. Poster presented at the 2018 Winter Clinical Dermatology Conference; January 2018. Hawaii. [abstract] Skin: the journal of cutaneous medicine. 2018 Feb 23; 2(2018). doi: 10.25251/skin.2.supp.25

Critchlow C, Chinn C, Price MA. Blurring the division between clinical and observational studies. Presented at the 9th Annual SCOPE Summit Conference; February 13, 2018. Orlando, FL.

Price MA, Richardson D. Value of conducting feasibility studies in observational research. Presented at the 9th Annual SCOPE Summit Conference; February 13, 2018. Orlando, FL.

Vanegas A, Vargas JM, Kukafka R, Crew KD. Randomized controlled trial of web-based decision support tools for high-risk women and primary care providers to increase breast cancer chemoprevention. Poster presented at the 2017 San Antonio Breast Cancer Symposium; December 2017. San Antonio, TX. [abstract] Cancer Res. 2018 Feb; 78(4 Suppl). doi: 10.1158/1538-7445.SABCS17-OT3-01-02

Trivedi MS, Colbeth H, Yi H, Vanegas A, Starck R, Chung WK, Appelbaum PS, Kukafka R, Schechter I, Crew KD. Understanding factors associated with uptake of BRCA genetic testing among Orthodox Jewish women using a mixed-methods approach. Poster presented at the 2017 San Antonio Breast Cancer Symposium; December 2017. San Antonio, TX. [abstract] Cancer Res. 2018 Feb; 78(4 Suppl).

Devercelli G, Davis K, Brown M, Hollis K, Hunter S, Long J, Jain G, Banerji A. Burden of hereditary angioedema: findings from a US patient survey. Poster presented at the 2018 AAAAI/WAO Joint Congress; March 3, 2018. Orlando, FL. [abstract] J Allergy Clin Immunol. 2018 Feb; 141(2 Suppl):AB57. doi: 10.1016/j.jaci.2017.12.182

Douglas AG, Schwab P, Lane D, Kennedy K, Slabaugh SL, Bowe A. A comparison of brand and biosimilar granulocyte-colony stimulating factors for prophylaxis of chemotherapy-induced febrile neutropenia. J Manag Care Spec Pharm. 2017 Dec;23(12):1221-6. doi: 10.18553/jmcp.2017.23.12.1221

Maurer M, Abuzakouk M, Berard F, Canonica W, Oude Elberink H, Gimenez-Arnau A, Grattan C, Hollis K, Knulst A, Lacour JP, Lynde C, Marsland A, McBride D, Nakonechna A, Ortiz De Frutos J, Proctor C, Sussman G, Sweeney C, Tian H, Weller K, Wolin D, Balp M-M. The burden of chronic spontaneous urticaria is substantial: real-world evidence from ASSURE-CSU. Allergy. 2017 Dec;27(12):2005-16. doi: 10.1111/all.13209

Levine CA, Ansquer V. Ethical considerations: conducting retrospective non-interventional medical record review studies in Europe. Poster presented at the 2017 ISPOR 20th Annual European Congress; November 8, 2017. Glasgow, Scotland.

Wheeler AC, Sacco P, Cabo R. Unmet clinical needs and burden in Angelman syndrome: a review of the literature. Orphanet J Rare Dis. 2017 Oct 16;12(1):164. doi: 10.1186/s13023-017-0716-z

Davis KH, Su J, Gonzalez JM, Trudeau JT, Nelson LM, Hauber B, Hollis KA. Quantifying the importance of inhaler attributes corresponding to items in the patient satisfaction and preference questionnaire in patients using Combivent Respimat. Health Qual Life Outcomes. 2017 Oct 16;15(1):201. doi: 10.1186/s12955-017-0780-z

Sluga-O'Callaghan M, Ansquer V, Frugier G, Mai C. Regulatory requirements for non-interventional studies collecting patient preferences and experiences in France, Germany and the UK. Poster presented at the 2017 ISPOR 20th Annual European Congress; November 2017. Glasgow, Scotland. [abstract] Value Health. 2017 Oct; 20(9):A707.

Davis KH, Asiimwe A, Zografos LJ, McSorley DJ, Andrews EB. Evaluation of risk-minimization activities for cyproterone acetate 2 mg/ethinylestradiol 35 μg: a cross-sectional physician survey. Pharmaceut Med. 2017 Oct;31(5):339-51. doi: 10.1007/s40290-017-0203-9

Banerji A, Davis KH, Devercelli G, Hollis K, Hunter S, Jain G. Clinical and demographic characteristics of patients with hereditary angioedema in the United States. Poster presented at the American College of Allergy, Asthma, and Immunology 2017 Annual Scientific Meeting; October 2017. Boston, MA.

Quittner AL, Alpern AN, Wolin D, McLeod L, Downey C, Nelson L, Khandelwal N. Psychometric analyses of a new GI symptom tracker for cystic fibrosis. Poster presented at the 31st Annual North American Cystic Fibrosis Conference; September 19, 2017. Indianapolis, IN. [abstract] Pediatr Pulmonol. 52(S47):453.

Quittner AL, Alpern AN, Wolin D, McLeod L, Downey C, Nelson L, Khandelwal N. Pysychometric analyses of a new GI symptom tracker for cystic fibrosis. Poster presented at the 31st Annual North American Cystic Fibrosis Conference; November 2, 2017. Indianapolis, IN. [abstract] Pediatr Pulmonol. 2017 Sep 19; 52(S47):S453. doi: 10.1002/ppul.23840

Sussman G, Abuzakouk M, Berard F, Canonica GW, Gimenez-Arnau A, Grattan C, Hollis K, Khalil S, Knulst AC, Lacour J-P, Lynde C, Marsland A, Maurer M, McBride D, Nakonechna A, Ortiz de Frutoz FJ, Oude Elberink JNG, Reynolds M, Weller K, Balp M-M. Angioedema in patients with chronic spontaneous urticaria has an additional impact of quality of life but is reported more often by patients than physicians. Presented at the 26th EADV Congress; September 16, 2017. Geneva, Switzerland.

Strober B, Zhao Y, Herrera V, Wolin D, McLeod L, Eid D, Bello T. Secukinumab provides greater symptom control in psoriasis-related pain, itching, and scaling compared with previous treatments: evidence from a real-world study in the US. Poster presented at the 26th EADV Congress; September 13, 2017. Geneva, Switzerland.

Strober B, Zhao Y, Herrera V, Wolin D, McLeod L, Davenport E, Bello T. Secukinumab patients achieve high overall treatment satisfaction and psoriasis-related and symptom improvement in a real world setting. Presented at the 26th EADV Congress; September 13, 2017. Geneva, Switzerland.

Trivedi MS, Coe AM, Vanegas A, Kukafka R, Crew KD. Chemoprevention uptake among women with atypical hyperplasia and lobular and ductal carcinoma in situ. Cancer Prev Res. 2017 Aug;10(8):434-41. doi: 10.1158/1940-6207.CAPR-17-0100

Zografos LJ, Andrews EB, Wolin DL, Calingaert B, Davenport EK, Hollis KA, Petraro P, Djokanovic N, Racanelli VS, Vassilev Z. Evaluating physician knowledge of safety information for aflibercept (Eylea). Poster presented at the 33rd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 30, 2017. Montreal, Canada. [abstract] Pharmacoepidemiol Drug Saf. 2017 Aug; 26(Suppl 2):592. doi: 10.1002/pds

Raspa M, Sacco P, Bailey DB, Visootak J, Cabo R. Clinical unmet needs and burden in fragile X syndrome: results of a targeted literature review. Poster presented at the American Association on Intellectual and Development Disabilities 141st Annual Meeting; June 27, 2017. Hartford, CT.

Marsland A, Abuzakouk M, Balp M-M, Berard F, Canonica GW, Gimenez-Arnau A, Grattan C, Hollis K, Hunter S, Khalil S, Knulst AC, Lacour L-P, Lynde C, McBride D, Nakonechna A, Ortiz de Frutoz FJ, Oude Elberink JNG, Sussman G, Tian H, Weller K, Maurer M. Chronic spontaneous/idiopathic urticaria patients with moderate activity have similar burden of disease as those with severe activity - results from the ASSURE-CSU study. Presented at the EAACI Congress 2017; June 20, 2017. Helsinki, Finland.

Gimenez-Arnau A, Abuzakouk M, Balp M-M, Berard F, Canonica GW, Grattan C, Hollis K, Hunter S, Khalil S, Knulst AC, Lacour J-P, Lynde C, Marsland A, McBride D, Nakonechna A, Ortiz de Frutoz FJ, Oude Elberink JNG, Sussman G, Tian H, Weller K, Maurer M. Economic and humanistic burden associated with angioedema in patients with chronic spontaneous/idiopathic urticaria. Poster presented at the EAACI Congress 2017; June 20, 2017. Helsinki, Finland.

Li X, McGuinness JE, Vanegas A, Colbeth H, Vargas J, Sandoval R, Kukafka R, Crew KD. Identifying women at high-risk for breast cancer using data from the electronic health record compared with self-report. J Clin Oncol. 2017 May 30;35(15_Suppl):e13044. doi: 10.1200/JCO.2017.35.15_suppl.e13044

Telfort J, Trivedi MS, Yi HS, Colbeth H, Vanegas A, Vargas J, Sandoval R, Wood J, Dimond J, Finkelstein J, Kukafka R, Crew KD. Implementing decision support for breast cancer chemoprevention in primary care. J Clin Oncol. 2017 May;35(15 Suppl):e13038. doi: 10.1200/JCO.2017.35.15_suppl.e13038

McGuinness JE, Trivedi MS, Vanegas A, Colbeth H, Sandoval R, Kukafka R, Crew KD. Decision support for family history intake to determine eligibility for BRCA testing among multiethnic women. J Clin Oncol. 2017 May;35(15_Suppl):1586. doi: 10.1200/JCO.2017.35.15_suppl.1586

Sluga-O'Callaghan M, Derrien Ansquer V, Mai C. Evolution of regulatory requirements for retrospective observational studies using medical records in France, Germany, Spain and the UK. Poster presented at the 2017 ISPOR 22nd Annual International Meeting; May 2017. Boston, MA. [abstract] Value Health. 2017 May; 20(2017):A68.

Schwab P, Dhamane AD, Hopson SD, Moretz C, Annavarapu S, Burslem K, Renda A, Kaila S. Impact of comorbid conditions in COPD patients on health care resource utilization and costs in a predominantly Medicare population. Int J Chron Obstruct Pulmon Dis. 2017 Feb 23;12:735-44. doi: 10.2147/COPD.S112256

Coe AM, Ueng W, Vargas JM, David R, Vanegas A, Infante K, Trivedi M, Yi H, Dimond J, Crew KD, Kukafka R. Usability testing of a web-based decision aid for breast cancer risk assessment among multi-ethnic women. AMIA Annu Symp Proc. 2017 Feb 10;2016:411-20.

Ali-Shaw T, Ueng WA, Trivedi MS, Yi H, David RR, Vanegas A, Vargas JM, Sandoval R, Wood J, Kukafka R, Crew KD. Adherence to healthy lifestyle behaviors in a predominantly Hispanic population of women undergoing screening mammography. Poster presented at the 2016 San Antonio Breast Cancer Symposium; December 2016. San Antonio, TX. [abstract] Cancer Res. 2017 Feb; 77(4_Suppl). doi: 10.1158/1538-7445.SABCS16-P5-10-01

Coe AM, Trivedi MS, Vanegas A, Kukafka R, Crew KD. Chemoprevention uptake among women with atypical hyperplasia, lobular and ductal carcinoma in situ. Poster presented at the 2016 San Antonio Breast Cancer Symposium; December 2016. San Antonio, TX. [abstract] Cancer Res. 2017 Feb; 77(4_Suppl). doi: 10.1158/1538-7445.SABCS16-P2-07-01

Price MA, Hamm L. Synergies in the operationalization of clinical and observational studies. Presented at the 8th Annual SCOPE Summit Conference; January 24, 2017. Miami, FL.

Dhamane AD, Schwab P, Hopson S, Moretz C, Annavarapu S, Burslem K, Renda A, Kaila S. Association between adherence to medications for COPD and medications for other chronic conditions in COPD patients. Int J Chron Obstruct Pulmon Dis. 2016 Dec 22;12:115-22. doi: 10.2147/COPD.S114802

McRoy LL, Mitra D, Hollis K, Kaye JA, Zelnak A, Cheryl J. MADELINE: a prospective observational study of mobile-app based patient reported outcomes in advanced breast cancer. Poster presented at the 2016 San Antonio Breast Cancer Symposium; December 9, 2016. San Antonio, TX.